A Phase 1 clinical trial is evaluating an investigational vaccine designed to protect against coronavirus disease in Seattle.
The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks. The first participant received the investigational vaccineon Monday, March 16th.
The study is evaluating different doses of the experimental vaccine for safety, and its ability to induce an immune response in participants. This is the first of multiple steps in the clinical trial process for evaluating the potential benefit of the vaccine.
The investigational vaccine was developed using a genetic platform called mRNA. The investigational vaccine directs the body’s cells to express a virus protein that it is hoped will elicit a robust immune response.
The mRNA-1273 vaccine has shown promising results in animal models, and this is the first tiem it will be used on humans.
The Yucatan Times
Newsroom
Comments
more recommended stories
Puerto Vallarta invites you to move in and Work from a BeachInspired Living: Work from a Beach.
Enrique Rebsamen School owner convicted in 2017 collapseCDMX (September 19, 2020).- The owner.
Lucha libre wrestlers struggle to survive amid virusFew of Mexico’s cultural traditions have.
AMLO – The thrill is goneThe reality of Mexico’s President, Andrés.
What will happen to TikTok after Trump’s ban?The United States will restrict the.
Intellectuals demand that López Obrador not attack freedom of expression. He strikes back at them.More than 650 intellectuals demanded that.
Ruth Bader Ginsberg Dies, US Election Changes CourseSupreme Court Justice Ruth Bader Ginsburg,.
Seizures of fentanyl drug up 465% in MexicoMEXICO CITY (The Associated Press) —.
Gabriel Quadri invokes “TUMOR” All united against MorenaFormer presidential candidate Gabriel Quadri all.
Residents of Valladolid take justice on their own handVALLADOLID.— Tired that several robberies have.
BUSQUE A UN MÉDICO
Leave a Comment